![](/img/cover-not-exists.png)
Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-Amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin-6-yl)-(S)-ethyl]-2,5-thienoylamino-l-glutamic acid (AG2034): Comparison across sensitive and resistant human tumor cell lines
Hélène M. Faessel, Harry K. Slocum, Youcef M. Rustum, William R. GrecoVolume:
57
Year:
1999
Language:
english
Pages:
11
DOI:
10.1016/s0006-2952(98)00315-3
File:
PDF, 380 KB
english, 1999